NI
NextEvo, Inc.
SEC filingPharmaceuticals · Conshohocken, PA
Amount raised$725Ksold at filing
Total offeringNot stated
Investors in the raise1count reported to the SEC
FiledApr 29, 2026first sale Jan 13, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Ross DesmaraisExecutive Officer, Director
Gerry McNallyExecutive Officer
Gerald StahleckerExecutive Officer, Director
Cornelius MerliniDirector
Howard GoodwinExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.